(Securities Identification Code: 6856)
2 Miyanohigashi-cho, Kisshoin, Minami-ku,
Kyoto-shi
HORIBA, Ltd.
Masayuki Adachi, President & COO
March 6, 2020
Supplementary Explanation Concerning Agenda 1 and Agenda 2 ofthe 82nd Ordinary General Meeting of Shareholders
To Our Shareholders,
HORIBA, Ltd. is pleased to furnish the following supplementary explanation pertainingto Agenda 1 (“Election of eight (8) Directors”) and Agenda 2 (“Election of three (3) Corporate
Auditors”) under Items to be Resolved at the 82nd Ordinary General Meeting of Shareholders
scheduled to be convened on March 28, 2020, in the interest of further enhancing theunderstanding of our precious shareholders concerning this matter.
We encourage our shareholders to confirm the following contents, thereby raising theirawareness of the agendas in question.
1. Agenda 1 (Election of eight (8) Directors)
Candidate No. 8 (Dr. Sawako Takeuchi)
Note: Please refer to the Company’s Notice of the 82nd Ordinary General Meeting ofShareholders.
Dr. Sawako Takeuchi currently serves as Invited Professor at Yamagata University Faculty ofEngineering. The value of the transactions between the Company and the University concerning
research and development is less than 1 million yen, thereby comprising less than 0.01% of theaggregate income of the University during its most recent accounting year. Accordingly, thissatisfies the conditions pursuant to the “Independence Judgment Standards for Independent
Outside Directors and Auditors” stipulated by the Company and no issues are considered to exist
with regard to the independence of Dr. Takeuchi.

2. Agenda 2 (Election of three (3) Corporate Auditors)(1) Candidate No. 2 (Mr. Keiji Yamada)
Note: Please refer to the Company’s Notice of the 82nd Ordinary General Meeting ofShareholders.
Mr. Keiji Yamada currently serves as Advisor to the President of Kyoto Sangyo University, as
well as Department of Policy Studies Professor. The value of the transactions between theCompany and the University concerning research and development and other fields is less than 3
million yen, thereby comprising 0.01% of the aggregate business activity income of the University
during its most recent accounting year. Accordingly, this satisfies the conditions pursuant to the“Independence Judgment Standards for Independent Outside Directors and Auditors” stipulatedby the Company and no issues are considered to exist with regard to the independence of Mr.
Yamada.
(2) Candidate No. 3 (Ms. Tomoko Tanabe)
Note: Please refer to the Company’s Notice of the 82nd Ordinary General Meeting ofShareholders.
Ms. Tomoko Tanabe currently serves as President of Kyoto Medical Club Co., Ltd.(hereinafterreferred to as “Kyoto Medical Club”). The value of the transactions between the Company andKyoto Medical Club concerning annual medical checkup and other matters is less than 2 million
yen, thereby comprising 0.42% of the aggregate net sales of Kyoto Medical Club during its mostrecent accounting year. Accordingly, this satisfies the conditions pursuant to the “Independence
Judgment Standards for Independent Outside Directors and Auditors” stipulated by the Companyand no issues are considered to exist with regard to the independence of Ms. Tanabe.